XBiotech Inc
NASDAQ:XBIT

Watchlist Manager
XBiotech Inc Logo
XBiotech Inc
NASDAQ:XBIT
Watchlist
Price: 2.52 USD -0.4% Market Closed
Market Cap: 76.8m USD

During the last 3 months XBiotech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 5% over this period (open performance analysis).

The last transaction was made on Jan 3, 2024 by Simard John , who bought 24.7T USD worth of XBIT shares.

Last Transactions:
Simard John
$+24.7T
Simard John
$-431.3k
Simard John
$-226.5k
Simard John
$-272.5k
Simard John
$-139.5k
Simard John
$-229.9k
Simard John
$-489.1k
Simard John
$-134.3k
Simard John
$-180.1k
Simard John
$-309.9k
Simard John
$-260.5k
Simard John
$-242.5k
Simard John
$-219.8k
Simard John
$-89.4k
Simard John
$-442.8k
Simard John
$-165.4k
Simard John
$-145.2k
Simard John
$-297.8k
Simard John
$-256.9k
Simard John
$-202.9k
Simard John
$-907.4k
Bay Street Financial S.a.
$-22m
Bay Street Financial S.a.
$-3.4m
Mckenzie W Thorpe
$-6.9m
Shivaswamy Sushma
$-413.4k
Shivaswamy Sushma
$-386.8k
Han Queena
$-367.5k
Han Queena
$-25.1k
Bay Street Financial S.a.
$-10.6m
Mckenzie W Thorpe
$-26.4k
Rennes Fondation
$+9.9m
Rennes Fondation
$+129.9k
View All Transactions

During the last 3 months XBiotech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 5% over this period (open performance analysis).

The last transaction was made on Jan 3, 2024 by Simard John , who bought 24.7T USD worth of XBIT shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

XBiotech Inc
Insider Trading Chart

XBiotech Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

XBiotech Inc
Last Insider Transactions

Global
Insiders Monitor

XBiotech Inc
Glance View

Market Cap
76.8m USD
Industry
Biotechnology

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 97 full-time employees. The company went IPO on 2015-04-15. The firm is focused on the therapies that block a potent substance naturally produced by body, known as interleukin-1 alpha (IL-1a), that mediates tissue breakdown, angiogenesis, the formation of blood clots and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma. Its True Human antibodies have the potential to harness the body's natural immunity to fight disease with increased safety, efficacy and tolerability. The firm has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. The firm is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure.

XBIT Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top